Tag: Syros Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Syros Pharmaceuticals

Syros Pharmaceuticals (NASDAQ:SYRS) Downgraded by ValuEngine to “Sell”

Added to Collection on: 2018-06-26 19:36:57

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
JPMorgan Chase & Co. Boosts Holdings in Syros Pharmaceuticals (SYRS)

Added to Collection on: 2018-07-01 17:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (SYRS) Receives $22.43 Average Price Target from Analysts

Added to Collection on: 2018-07-06 22:59:53

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (SYRS) Holdings Increased by Schwab Charles Investment Management Inc.

Added to Collection on: 2018-07-07 17:33:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals' (SYRS) “Buy” Rating Reiterated at Cowen

Added to Collection on: 2018-07-17 04:15:23

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals' (SYRS) Buy Rating Reaffirmed at Cowen

Added to Collection on: 2018-07-17 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Cowen Reaffirms “Buy” Rating for Syros Pharmaceuticals (SYRS)

Added to Collection on: 2018-08-09 07:34:42

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (NASDAQ:SYRS) Receives Buy Rating from Cann

Added to Collection on: 2018-08-17 00:07:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (NASDAQ:SYRS) Price Target Cut to $16.00

Added to Collection on: 2019-10-19 19:26:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syros Acquires Clinical-Stage Drug Candidate for Acute Promyelocytic Leukemia, Expanding Its ...

Added to Collection on: 2020-12-05 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Book a Demo